Omidubicel-onlv (Omisirge) — medical necessity and coverage criteria for intravenous infusion
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
Policy governs medical necessity coverage and administrative requirements for omidubicel-onlv (Omisirge) IV infusion for eligible patients receiving umbilical cord blood transplantation or with severe aplastic anemia, affecting providers and prior authorization for Blue Cross NC members.
Added applicable revenue codes 0891 and 0892 associated with policy HCPCS code(s).
Original medical policy criteria issued and policy put on notice for effective date April 1, 2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.